Inventor · disambiguated record
Aaron M. Bender
Also filed as: BENDER AARON M
10 granted patents·17 pending applications·23 citations·filing 2016–2023
84Inventor score
Files withUNIV VANDERBILT27
Top patents by PatentIndex Score
27 records- 0195US11820757B2Antagonists of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2022·Granted Nov 21, 2023·5 cites·20 claims
- 0290US11299481B2Antagonists of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2018·Granted Apr 12, 2022·5 cites·20 claims
- 0389US11149022B2Antagonists of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2018·Granted Oct 19, 2021·4 cites·20 claims
- 0486US12319701B2Antagonists of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2020·Granted Jun 3, 2025·2 cites·20 claims
- 0586US11414406B2Antagonists of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2019·Granted Aug 16, 2022·3 cites·20 claims
- 0681US11325896B2Antagonists of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2018·Granted May 10, 2022·2 cites·20 claims
- 0779US10710997B2Isoquinoline amide and isoquinoline amide-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunctionUNIV VANDERBILT·Filed 2017·Granted Jul 14, 2020·1 cites·34 claims
- 0874US10221175B2Substituted pyrrolo[3,4-e]indolizines, imidazo[1,2-a]pyrrolo[3,4-e]pyridines, pyrrolo[3,4-e][1,2,4]triazolo[1,5-a]pyridines and pyrrolo[3,4-e][1,2,4]triazolo[4,3-a]pyridines as positive allosteric modulators of muscarinic acetylcholine receptor M1UNIV VANDERBILT·Filed 2016·Granted Mar 5, 2019·1 cites·19 claims
- 0959US2025026752A1Positive allosteric modulators of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 1059US2025101041A1Positive allosteric modulators of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2023·Application pending·0 cites
- 1159US2025017935A17,8-dihydro-5h-1,6-naphthyridine derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4 for treating neurological and psychiatric disordersUNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 1255US2025145595A1Antagonists of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 1354US2023183218A1Condensed substituted hydropyrroles as antagonists of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2021·Application pending·0 cites
- 1454US2024228468A1N-(6-((octahydrocyclopenta[c]pyrrol-5-yi)amino)pyridazin-3-yl)phenyl)carboxamide and (6- ((octahydrocyclopenta[c]pyrrol-5-yl)amino)pyridazin-3-yl)benzamide derivatives as machr m4 antagonists for the treatment of neurodegenerative disordersUNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 1554US2024174655A1Indazole derivatives as antagonists of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 1653US2024287050A1(4-(6-((2-octahydrocyclopenta[c]pyrrol-5-yl)amino)pyridazin-3-yl)phenyl)(imino)(methyl)-lambda6- sulfanone derivatives and similar compounds as muscarinic acetylcholine receptor m4 antagonists for the treatment of neurodegenerative disordersUNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 1753US2025026743A1Heteroaryl-linked analogs as mglu5 negative allosteric modulators and methods of making and using the sameUNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 1852US11851406B2Positive allosteric modulators of the muscarinic acetylcholine receptor M1UNIV VANDERBILT·Filed 2019·Granted Dec 26, 2023·0 cites·20 claims
- 1952US2024010640A1Antagonists of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2021·Application pending·0 cites
- 2051US2023183219A1Condensed substituted hydropyrroles as antagonists of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2021·Application pending·0 cites
- 2150US2024109873A1Antagonists of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2021·Application pending·0 cites
- 2249US12065433B2Positive allosteric modulators of the muscarinic acetylcholine receptor M1UNIV VANDERBILT·Filed 2019·Granted Aug 20, 2024·0 cites·18 claims
- 2349US2023122344A1Antagonists of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2020·Application pending·0 cites
- 2447US2023150986A1Antagonists of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2020·Application pending·0 cites
- 2547US2020131159A1Positive allosteric modulators of the muscarinic acetylcholine receptor m1UNIV VANDERBILT·Filed 2019·Application pending·0 cites
- 2646US2020131180A1Positive allosteric modulators of the muscarinic acetylcholine receptor m1UNIV VANDERBILT·Filed 2019·Application pending·0 cites
- 2744US2019330226A1Positive allosteric modulators of the muscarinic acetylcholine receptor m1UNIV VANDERBILT·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Aaron M. Bender files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →